%0 Generic %A Kim, Yong-Chul %A Jun Chin, Ho %A Suk Koo, Ho %A Kim, Suhnggwon %D 2013 %T The clinical results of patients stratified with ARB medication at randomization. %U https://plos.figshare.com/articles/dataset/_The_clinical_results_of_patients_stratified_with_ARB_medication_at_randomization_/776306 %R 10.1371/journal.pone.0071545.t003 %2 https://plos.figshare.com/ndownloader/files/1174789 %K statistics %K Biostatistics %K Statistical methods %K Clinical research design %K clinical trials %K Drugs and devices %K Adverse reactions %K Clinical pharmacology %K Drug information %K Drug research and development %K Nephrology %K Chronic kidney disease %K hypertension %K patients %K stratified %K arb %X *

ARB: Angiotensin II type I receptor blocker. Percent changes of UACR: calculated by level of UACR at each visit compared to level of baseline. Final value: mean value of UACR at 12 weeks and 16 weeks. Secondary outcome: levels of UACR or UPCR at 16 weeks compared to level of baseline. Baseline value: mean value of UACR or UPCR at screening period and randomization period (0 week).

%I PLOS ONE